3 research outputs found

    Features of the course of manifest forms of acute hepatitis C

    Get PDF
    Aim. To identify clinical, epidemiological and laboratory-instrumental features of acute hepatitis C at the present stage according to the infectious hospital data. Methods. The study included 111 patients with acute hepatitis C aged from 18 to 79 years who were hospitalized in Republican Clinical Infectious Diseases Hospital named after A.F. Agafonov in 2011 - I quarter of 2017. Acute hepatitis C was diagnosed in accordance with the guidelines of the Ministry of Health of the Russian Federation. Results. In the study group, females aged 21 to 40 years, non-working, predominantly living in Kazan with medical transmission of infection (34 %) prevailed. The disease was mild and moderately severe (71 %). The icteric form was observed in 94 % of patients, in 3.6 % - with a cholestatic component. When comparing laboratory parameters, markers of cytolysis and cholestasis differed significantly in patients depending on the severity (p<0.001). Changes in the gallbladder walls (an ultrasound marker of cholestasis) were revealed in 21.4 % of patients. On specific examination, the viral RNA was detected in 100 % of patients. Analysis of serological markers revealed predominance of antibodies to core and NS3 proteins, M class antibodies were detected only in half of the patients. Specific antibodies were absent (β€œdark diagnostic window”) in 3 % of patients with mild and 6 % of moderate form of the disease. Conclusion. The feature of the course of acute viral hepatitis C was the predominance of moderate forms (71 %) with medical transmission of infection. Icteric forms of acute viral hepatitis C were diagnosed in 94 % of patients (in 3.6 % cases with the development of cholestatic component). PCR is a mandatory method of specific diagnosis of acute viral hepatitis C, and in case of a β€œdark diagnostic window” becomes the leading method

    ЭпидСмиологичСская характСристика папилломавирусной ΠΈΠ½Ρ„Π΅ΠΊΡ†ΠΈΠΈ Π°Π½ΠΎΠ³Π΅Π½ΠΈΡ‚Π°Π»ΡŒΠ½ΠΎΠΉ Π»ΠΎΠΊΠ°Π»ΠΈΠ·Π°Ρ†ΠΈΠΈ Π² РСспубликС Ватарстан

    Get PDF
    Due to the high prevalence of anogenital warts, their significant economic and psychosocial burden, the lack of routine vaccination against papillomavirus infection, monitoring of the epidemiological situation for one of the common forms of papillomavirus infection – anogenital warts is relevant.The aim is to assess the epidemiological situation of anogenital warts in Tatarstan Republic for 2011–2020.Materials and methods. The study design is an observational descriptive epidemiological study. A retrospective epidemiological analysis of the incidence of anogenital warts in Tatarstan Republic for 2011–2020 was carried out. The analysis of long-term dynamics of incidence of the population as a whole and in age and sex groups is carried out. The structure of the incidence of anogenital warts was assessed. Intensive (per 100,000) and extensive morbidity rates (%) were calculated.Results. There is a decrease in the incidence of anogenital warts in Republic Tatarstan from 123,80/0000 in 2011 to 68,80/0000 in 2020. The dynamics of the incidence of anogenital warts among the female and male population had a unidirectional character – a decrease in the incidence. A comparison of incidence levels showed that the incidence of women was higher than that of men (80,40/0000 versus 55,80/0000, respectively, in 2020). The greatest incidence of anogenital warts was observed in the 18–29 age group during the observation period. The average annual incidence of anogenital warts in women aged 18–29 was 535,60/0000, in men of the same age group – 233,00/0000.Conclusion. Despite the decrease in the incidence of anogenital warts in Tatarstan Republic as a whole and in certain age and gender groups, high levels of incidence among people aged 18-29 years remain. The data obtained from the results of a retrospective analysis of the incidence of anogenital warts indicate the need to introduce routine vaccination against HPV infection, which will prevent large treatment costs, and will have a positive impact on public health indicators.Π’ силу высокой распространСнности Π°Π½ΠΎΠ³Π΅Π½ΠΈΡ‚Π°Π»ΡŒΠ½Ρ‹Ρ… Π±ΠΎΡ€ΠΎΠ΄Π°Π²ΠΎΠΊ, ΠΈΡ… сущСствСнного экономичСского ΠΈ ΠΏΡΠΈΡ…ΠΎΡΠΎΡ†ΠΈΠ°Π»ΡŒΠ½ΠΎΠ³ΠΎ Π±Ρ€Π΅ΠΌΠ΅Π½ΠΈ, отсутствия ΠΏΠ»Π°Π½ΠΎΠ²ΠΎΠΉ Π²Π°ΠΊΡ†ΠΈΠ½Π°Ρ†ΠΈΠΈ ΠΏΡ€ΠΎΡ‚ΠΈΠ² папилломавирусной ΠΈΠ½Ρ„Π΅ΠΊΡ†ΠΈΠΈ прСдставляСтся Π°ΠΊΡ‚ΡƒΠ°Π»ΡŒΠ½Ρ‹ΠΌ ΠΏΡ€ΠΎΠ²Π΅Π΄Π΅Π½ΠΈΠ΅ ΠΌΠΎΠ½ΠΈΡ‚ΠΎΡ€ΠΈΠ½Π³Π° эпидСмиологичСской ситуации Π·Π° ΠΎΠ΄Π½ΠΎΠΉ ΠΈΠ· распространСнных Ρ„ΠΎΡ€ΠΌ папилломавирусной ΠΈΠ½Ρ„Π΅ΠΊΡ†ΠΈΠΈ – Π°Π½ΠΎΠ³Π΅Π½ΠΈΡ‚Π°Π»ΡŒΠ½Ρ‹ΠΌΠΈ Π±ΠΎΡ€ΠΎΠ΄Π°Π²ΠΊΠ°ΠΌΠΈ.ЦСль: ΡƒΡΡ‚Π°Π½ΠΎΠ²ΠΈΡ‚ΡŒ закономСрности проявлСний эпидСмичСского процСсса Π°Π½ΠΎΠ³Π΅Π½ΠΈΡ‚Π°Π»ΡŒΠ½Ρ‹Ρ… Π±ΠΎΡ€ΠΎΠ΄Π°Π²ΠΎΠΊ Π² РСспубликС Ватарстан Π·Π° ΠΏΠ΅Ρ€ΠΈΠΎΠ΄ с 2011 ΠΏΠΎ 2020 Π³.ΠœΠ°Ρ‚Π΅Ρ€ΠΈΠ°Π»Ρ‹ ΠΈ ΠΌΠ΅Ρ‚ΠΎΠ΄Ρ‹. Π”ΠΈΠ·Π°ΠΉΠ½ исслСдования – обсСрвационноС ΠΎΠΏΠΈΡΠ°Ρ‚Π΅Π»ΡŒΠ½ΠΎΠ΅ эпидСмиологичСскоС исслСдованиС. ΠŸΡ€ΠΎΠ²Π΅Π΄Π΅Π½ рСтроспСктивный эпидСмиологичСский Π°Π½Π°Π»ΠΈΠ· заболСваСмости Π°Π½ΠΎΠ³Π΅Π½ΠΈΡ‚Π°Π»ΡŒΠ½Ρ‹ΠΌΠΈ Π±ΠΎΡ€ΠΎΠ΄Π°Π²ΠΊΠ°ΠΌΠΈ Π² РСспубликС Ватарстан Π·Π° 2011–2020 Π³Π³. ΠŸΡ€ΠΎΠ²Π΅Π΄Π΅Π½ Π°Π½Π°Π»ΠΈΠ· ΠΌΠ½ΠΎΠ³ΠΎΠ»Π΅Ρ‚Π½Π΅ΠΉ Π΄ΠΈΠ½Π°ΠΌΠΈΠΊΠΈ заболСваСмости насСлСния Π² Ρ†Π΅Π»ΠΎΠΌ ΠΈ Π² возрастных ΠΈ ΠΏΠΎΠ»ΠΎΠ²Ρ‹Ρ… Π³Ρ€ΡƒΠΏΠΏΠ°Ρ…. ΠŸΡ€ΠΎΠ²Π΅Π΄Π΅Π½Π° ΠΎΡ†Π΅Π½ΠΊΠ° структуры заболСваСмости Π°Π½ΠΎΠ³Π΅Π½ΠΈΡ‚Π°Π»ΡŒΠ½Ρ‹ΠΌΠΈ Π±ΠΎΡ€ΠΎΠ΄Π°Π²ΠΊΠ°ΠΌΠΈ. Рассчитаны интСнсивныС (Π½Π° 100 000) ΠΈ экстСнсивныС ΠΏΠΎΠΊΠ°Π·Π°Ρ‚Π΅Π»ΠΈ заболСваСмости (%).Π Π΅Π·ΡƒΠ»ΡŒΡ‚Π°Ρ‚Ρ‹. ΠžΡ‚ΠΌΠ΅Ρ‡Π°Π΅Ρ‚ΡΡ сниТСниС заболСваСмости Π°Π½ΠΎΠ³Π΅Π½ΠΈΡ‚Π°Π»ΡŒΠ½Ρ‹ΠΌΠΈ Π±ΠΎΡ€ΠΎΠ΄Π°Π²ΠΊΠ°ΠΌΠΈ Π² РСспубликС Ватарстан с 123,80/0000 Π² 2011 Π³. Π΄ΠΎ 68,80/0000 Π² 2020 Π³. Π”ΠΈΠ½Π°ΠΌΠΈΠΊΠ° Π³ΠΎΠ΄ΠΎΠ²Ρ‹Ρ… ΠΏΠΎΠΊΠ°Π·Π°Ρ‚Π΅Π»Π΅ΠΉ заболСваСмости Π°Π½ΠΎΠ³Π΅Π½ΠΈΡ‚Π°Π»ΡŒΠ½Ρ‹ΠΌΠΈ Π±ΠΎΡ€ΠΎΠ΄Π°Π²ΠΊΠ°ΠΌΠΈ срСди ТСнского ΠΈ муТского насСлСния ΠΈΠΌΠ΅Π»Π° ΠΎΠ΄Π½ΠΎΠ½Π°ΠΏΡ€Π°Π²Π»Π΅Π½Π½Ρ‹ΠΉ Ρ…Π°Ρ€Π°ΠΊΡ‚Π΅Ρ€ – сниТСниС заболСваСмости. ΠŸΡ€ΠΈ сравнСнии интСнсивных ΠΏΠΎΠΊΠ°Π·Π°Ρ‚Π΅Π»Π΅ΠΉ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π΅ΠΌΠΎΡΡ‚ΡŒ ΠΆΠ΅Π½Ρ‰ΠΈΠ½ Π±Ρ‹Π»Π° Π²Ρ‹ΡˆΠ΅ заболСваСмости ΠΌΡƒΠΆΡ‡ΠΈΠ½ (80,40/0000 ΠΏΡ€ΠΎΡ‚ΠΈΠ² 55,8 0/0000 соотвСтствСнно, ΠΏΠΎ Π΄Π°Π½Π½Ρ‹ΠΌ 2020 Π³.). НаибольшиС ΠΏΠΎΠΊΠ°Π·Π°Ρ‚Π΅Π»ΠΈ заболСваСмости Π°Π½ΠΎΠ³Π΅Π½ΠΈΡ‚Π°Π»ΡŒΠ½Ρ‹ΠΌΠΈ Π±ΠΎΡ€ΠΎΠ΄Π°Π²ΠΊΠ°ΠΌΠΈ ΠΎΡ‚ΠΌΠ΅Ρ‡Π°ΡŽΡ‚ΡΡ Π² Π³Ρ€ΡƒΠΏΠΏΠ΅ 18–29 Π»Π΅Ρ‚ Π² Ρ‚Π΅Ρ‡Π΅Π½ΠΈΠ΅ всСго ΠΏΠ΅Ρ€ΠΈΠΎΠ΄Π° наблюдСния. Π‘Ρ€Π΅Π΄Π½Π΅ΠΌΠ½ΠΎΠ³ΠΎΠ»Π΅Ρ‚Π½ΠΈΠΉ ΠΏΠΎΠΊΠ°Π·Π°Ρ‚Π΅Π»ΡŒ заболСваСмости Π°Π½ΠΎΠ³Π΅Π½ΠΈΡ‚Π°Π»ΡŒΠ½Ρ‹ΠΌΠΈ Π±ΠΎΡ€ΠΎΠ΄Π°Π²ΠΊΠ°ΠΌΠΈ ΠΆΠ΅Π½Ρ‰ΠΈΠ½ 18–29 Π»Π΅Ρ‚ составил 535,60/0000, ΠΌΡƒΠΆΡ‡ΠΈΠ½ Ρ‚ΠΎΠΉ ΠΆΠ΅ возрастной Π³Ρ€ΡƒΠΏΠΏΡ‹ – 233,00/0000.Π—Π°ΠΊΠ»ΡŽΡ‡Π΅Π½ΠΈΠ΅. НСсмотря Π½Π° сниТСниС заболСваСмости Π°Π½ΠΎΠ³Π΅Π½ΠΈΡ‚Π°Π»ΡŒΠ½Ρ‹ΠΌΠΈ Π±ΠΎΡ€ΠΎΠ΄Π°Π²ΠΊΠ°ΠΌΠΈ, Π² РСспубликС Ватарстан Π² Ρ†Π΅Π»ΠΎΠΌ ΠΈ Π² ΠΎΡ‚Π΄Π΅Π»ΡŒΠ½Ρ‹Ρ… половозрастных Π³Ρ€ΡƒΠΏΠΏΠ°Ρ… ΡΠΎΡ…Ρ€Π°Π½ΡΡŽΡ‚ΡΡ высокиС ΠΏΠΎΠΊΠ°Π·Π°Ρ‚Π΅Π»ΠΈ заболСваСмости срСди Π»ΠΈΡ† 18–29 Π»Π΅Ρ‚. Π”Π°Π½Π½Ρ‹Π΅, ΠΏΠΎΠ»ΡƒΡ‡Π΅Π½Π½Ρ‹Π΅ ΠΏΠΎ Ρ€Π΅Π·ΡƒΠ»ΡŒΡ‚Π°Ρ‚Π°ΠΌ рСтроспСктивного Π°Π½Π°Π»ΠΈΠ·Π° заболСваСмости Π°Π½ΠΎΠ³Π΅Π½ΠΈΡ‚Π°Π»ΡŒΠ½Ρ‹ΠΌΠΈ Π±ΠΎΡ€ΠΎΠ΄Π°Π²ΠΊΠ°ΠΌΠΈ, ΡΠ²ΠΈΠ΄Π΅Ρ‚Π΅Π»ΡŒΡΡ‚Π²ΡƒΡŽΡ‚ ΠΎ нСобходимости внСдрСния ΠΏΠ»Π°Π½ΠΎΠ²ΠΎΠΉ Π²Π°ΠΊΡ†ΠΈΠ½Π°Ρ†ΠΈΠΈ ΠΏΡ€ΠΎΡ‚ΠΈΠ² Π’ΠŸΠ§-ΠΈΠ½Ρ„Π΅ΠΊΡ†ΠΈΠΈ (Ρ‡Π΅Ρ‚Ρ‹Ρ€Π΅Ρ…Π²Π°Π»Π΅Π½Ρ‚Π½ΠΎΠΉ Π²Π°ΠΊΡ†ΠΈΠ½ΠΎΠΉ), Ρ‡Ρ‚ΠΎ ΠΏΡ€Π΅Π΄ΠΎΡ‚Π²Ρ€Π°Ρ‚ΠΈΡ‚ Π½Π΅ Ρ‚ΠΎΠ»ΡŒΠΊΠΎ большиС Π·Π°Ρ‚Ρ€Π°Ρ‚Ρ‹ Π½Π° Π»Π΅Ρ‡Π΅Π½ΠΈΠ΅, Π½ΠΎ ΠΈ ΠΎΠΊΠ°ΠΆΠ΅Ρ‚ ΠΏΠΎΠ»ΠΎΠΆΠΈΡ‚Π΅Π»ΡŒΠ½ΠΎΠ΅ влияниС Π½Π° ΠΏΠΎΠΊΠ°Π·Π°Ρ‚Π΅Π»ΠΈ общСствСнного Π·Π΄ΠΎΡ€ΠΎΠ²ΡŒΡ

    ACTIVITY MONITORING OF A NTIBODIES TO HIV-1 STRUCTURAL PROTEINS IN A BSENCE OF ANTIRETROVIRAL TREATMENT AND IN THE COURSE OF THERAPY

    No full text
    Abstract. In HIV-infected patients, the process of antibody production to certain HIV-I structural proteins proceeds in differential manner, depending on the antigen localization. Upon progression of the disease, an increased ratio of antibodies to env surface glycoproteins is found, along with decreased percentage of antibodies to gag gene proteins
    corecore